Evaluating the cost-benefit profile of CPI stem cell therapy requires a comprehensive perspective. Supporters often highlight the potential for meaningful therapeutic outcomes, principally in diseases where conventional medications have proven limited. However, crucially important to consider the considerable financial expenditure associated with C